Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Venous thromboembolism and transfusion after major abdominopelvic surgery.

McAlpine K, Breau RH, Knee C, Carrier M, Violette PD, van Walraven C, McIsaac DI, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Surgery. 2019 Jul 31. pii: S0039-6060(19)30337-X. doi: 10.1016/j.surg.2019.05.050. [Epub ahead of print]

PMID:
31377000
2.

Regional Standardization of Prostate Multiparametric MRI Performance and Reporting: Is There a Role for a Director of Prostate Imaging?

Abreu-Gomez J, Shabana W, McInnes MDF, O'Sullivan JP, Morash C, Schieda N.

AJR Am J Roentgenol. 2019 Jun 10:1-7. doi: 10.2214/AJR.19.21111. [Epub ahead of print]

PMID:
31180739
3.

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W, Siemens R, So A, Leveridge MJ, Boorjian SA, Daneshmand S, Smith AB, Power N, Izawa J, Drachenberg DE, Fairey A, Rendon RA, Breau RH.

J Urol. 2019 May 17:101097JU0000000000000341. doi: 10.1097/JU.0000000000000341. [Epub ahead of print]

PMID:
31099720
4.

Editorial Comment.

Morash C.

J Urol. 2019 Mar;201(3):527. doi: 10.1097/01.JU.0000553711.58773.10. No abstract available.

PMID:
30759695
5.

Renal hypothermia during partial nephrectomy for patients with renal tumours: a randomised controlled clinical trial protocol.

Breau RH, Cagiannos I, Knoll G, Morash C, Cnossen S, Lavallée LT, Mallick R, Finelli A, Jewett M, Leibovich BC, Cook J, LeBel L, Kapoor A, Pouliot F, Izawa J, Rendon R, Fergusson DA.

BMJ Open. 2019 Jan 3;9(1):e025662. doi: 10.1136/bmjopen-2018-025662.

6.

Weight up? Changes in children's anthropometry from time of referral to baseline assessment for paediatric weight management.

Byrne JLS, O'Connor K, Peng C, Morash CL, Ball GDC.

Paediatr Child Health. 2018 Sep;23(6):377-382. doi: 10.1093/pch/pxx191. Epub 2018 Jan 11.

PMID:
30455574
7.

Standardized reporting templates with mandatory reporting fields and "pick-list" options improve use of Prostate Imaging and Data Reporting System version 2 in clinical practice: A plan-do-study-act analysis.

Moran K, Breau RH, Cagiannos I, Lavallée LT, Morash C, O'Sullivan J, Schieda N.

Can Urol Assoc J. 2019 Jun;13(6):212-214. doi: 10.5489/cuaj.5630. No abstract available.

8.

Robotic surgery improves transfusion rate and perioperative outcomes using a broad implementation process and multiple surgeon learning curves.

McAlpine K, Forster AJ, Breau RH, McIsaac D, Tufts J, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2019 Jun;13(6):184-189. doi: 10.5489/cuaj.5527.

9.

The effect of surgery report cards on improving radical prostatectomy quality: the SuRep study protocol.

Breau RH, Kumar RM, Lavallee LT, Cagiannos I, Morash C, Horrigan M, Cnossen S, Mallick R, Stacey D, Fung-Kee-Fung M, Morash R, Smylie J, Witiuk K, Fergusson DA.

BMC Urol. 2018 Oct 19;18(1):89. doi: 10.1186/s12894-018-0403-y.

10.

Female radical cystectomy patients have a higher risk of surgical site infections.

Abdi H, Elzayat E, Cagiannos I, Lavallée LT, Cnossen S, Flaman AS, Mallick R, Morash C, Breau RH.

Urol Oncol. 2018 Sep;36(9):400.e1-400.e5. doi: 10.1016/j.urolonc.2018.05.023. Epub 2018 Jul 29.

PMID:
30064934
11.

ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.

Sadoughi N, Krishna S, McInnes MDF, Flood TA, Breau RH, Morash C, Schieda N.

AJR Am J Roentgenol. 2018 Sep;211(3):W158-W165. doi: 10.2214/AJR.17.18958. Epub 2018 Jul 11.

PMID:
29995495
12.

Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.

Mcalpine K, Fergusson DA, Breau RH, Reynolds LF, Shorr R, Morgan SC, Eapen L, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2018 Oct;12(10):351-360. doi: 10.5489/cuaj.5244. Epub 2018 May 28. Review.

13.

Images: Ruptured intratesticular arteriovenous malformation.

Capitano M, Schieda N, Robertson SJ, Morash C, Breau RH, Maciejewski C, Flood TA.

Can Urol Assoc J. 2018 Nov;12(11):E489-E491. doi: 10.5489/cuaj.5049. Epub 2018 Jun 8. No abstract available.

14.

Multiparametric magnetic resonance imaging - Transrectal ultrasound-guided cognitive fusion biopsy of the prostate: Clinically significant cancer detection rates stratified by the Prostate Imaging and Data Reporting System version 2 assessment category.

John S, Cooper S, Breau RH, Flood TA, Cagiannos I, Lavallee LT, Morash C, O'sullivan J, Schieda N.

Can Urol Assoc J. 2018 Jun 19. doi: 10.5489/cuaj.5254. [Epub ahead of print]

15.

Reducing overtreatment of prostate cancer by radical prostatectomy in Eastern Ontario: a population-based cohort study.

Witherspoon L, Lau JL, Breau RH, Knee C, Fung MFK, Morash R, Mallick R, Cagiannos I, Morash C, Lavallée LT.

CMAJ Open. 2018 Apr 30;6(2):E197-E201. doi: 10.9778/cmajo.20170149.

16.

Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.

Breau RH, Lavallée LT, Cnossen S, Witiuk K, Cagiannos I, Momoli F, Bryson G, Kanji S, Morash C, Turgeon A, Zarychanski R, Mallick R, Knoll G, Fergusson DA.

Trials. 2018 May 2;19(1):261. doi: 10.1186/s13063-018-2626-3.

17.

Age-stratified perioperative mortality after urological surgeries.

Wallace B, Breau RH, Cnossen S, Knee C, Mcisaac D, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Can Urol Assoc J. 2018 Aug;12(8):256-259. doi: 10.5489/cuaj.5022. Epub 2018 Apr 6.

18.

Improving patient journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.

Kassouf W, Aprikian A, Saad F, Breau RH, Kulkarni G, Guttman DM, Bagshaw K, Izawa J, Eapen L, Fairey A, So A, North S, Rendon R, Sridhar SS, Brimo F, Chung P, Drachenberg D, Fradet Y, Jacobsen N, Morash C, Shayegan B, Gotto G, Zlotta A, Fleshner N, Siemens DR, Black PC.

Can Urol Assoc J. 2018 Jul;12(7):E281-E297. doi: 10.5489/cuaj.5246. Epub 2018 Mar 19. No abstract available.

19.

Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction.

Nayak AL, Cagiannos I, Lavallée LT, Morash C, Hickling D, Mallick R, Breau RH.

Can Urol Assoc J. 2018 Jun;12(6):181-186. doi: 10.5489/cuaj.4877. Epub 2018 Feb 23.

20.

Long-term patient outcomes from the first year of a robotic surgery program using multi-surgeon implementation.

Montroy J, Elzayat E, Morash C, Blew B, Lavallée LT, Cagiannos I, Watterson J, Oake JS, Fungkeefung M, Thompson C, Weber R, Breau RH.

Can Urol Assoc J. 2018 Feb;12(2):38-43. doi: 10.5489/cuaj.4528. Epub 2017 Dec 1.

21.

Editorial Comment.

Morash C.

J Urol. 2018 Apr;199(4):959-960. doi: 10.1016/j.juro.2017.10.062. Epub 2018 Jan 9. No abstract available.

PMID:
29328923
22.

Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in grade group 5 prostate cancer.

Flood TA, Schieda N, Sim J, Breau RH, Morash C, Belanger EC, Robertson SJ.

Virchows Arch. 2018 Feb;472(2):205-212. doi: 10.1007/s00428-017-2241-9. Epub 2017 Oct 3.

PMID:
28975495
23.

An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients.

da Silva V, Cagiannos I, Lavallée LT, Mallick R, Witiuk K, Cnossen S, Eastham JA, Fergusson DA, Morash C, Breau RH.

Can Urol Assoc J. 2017 Aug;11(8):238-243. doi: 10.5489/cuaj.4093.

24.

Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).

Lavallée LT, Fitzpatrick R, Wood LA, Basiuk J, Knee C, Cnossen S, Mallick R, Witiuk K, Vanhuyse M, Tanguay S, Finelli A, Jewett MAS, Basappa N, Lattouf JB, Gotto GT, Al-Asaaed S, Bjarnason GA, Moore R, North S, Canil C, Pouliot F, Soulières D, Castonguay V, Kassouf W, Cagiannos I, Morash C, Breau RH.

J Cancer Educ. 2019 Feb;34(1):14-18. doi: 10.1007/s13187-017-1259-7.

PMID:
28779441
25.

Are renal tumour scoring systems better than clinical judgement at predicting partial nephrectomy complexity?

Kumar RM, Lavallée LT, Desantis D, Cnossen S, Mallick R, Cagiannos I, Morash C, Breau RH.

Can Urol Assoc J. 2017 Jun;11(6):199-203. doi: 10.5489/cuaj.4228.

26.

Editorial Comment.

Morash C.

J Urol. 2017 Sep;198(3):598-599. doi: 10.1016/j.juro.2017.03.150. Epub 2017 Jun 17. No abstract available.

PMID:
28628757
27.

A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma.

Patel P, Nayak JG, Liu Z, Saarela O, Jewett M, Rendon R, Kapoor A, Black P, Tanguay S, Kawakami J, Moore R, Breau RH, Morash C, Pouliot F, Drachenberg DE.

J Endourol. 2017 Jul;31(7):645-650. doi: 10.1089/end.2016.0787.

PMID:
28381117
28.

The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis.

Montroy J, Fergusson NA, Hutton B, Lavallée LT, Morash C, Cagiannos I, Cnossen S, Fergusson DA, Breau RH.

Transfus Med Rev. 2017 Jul;31(3):141-148. doi: 10.1016/j.tmrv.2017.03.002. Epub 2017 Mar 22. Review.

PMID:
28366637
29.

The Risks and Benefits of Cavernous Neurovascular Bundle Sparing during Radical Prostatectomy: A Systematic Review and Meta-Analysis.

Nguyen LN, Head L, Witiuk K, Punjani N, Mallick R, Cnossen S, Fergusson DA, Cagiannos I, Lavallée LT, Morash C, Breau RH.

J Urol. 2017 Oct;198(4):760-769. doi: 10.1016/j.juro.2017.02.3344. Epub 2017 Mar 9.

PMID:
28286069
30.

Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy.

Lim CS, McInnes MDF, Flood TA, Breau RH, Morash C, Thornhill RE, Schieda N.

AJR Am J Roentgenol. 2017 May;208(5):1037-1044. doi: 10.2214/AJR.16.16843. Epub 2017 Mar 7.

PMID:
28267359
31.

Erratum to "The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System" [Urol Oncol 34(11) (2016) 486.e1-486.e7].

Mason R, Kapoor A, Liu Z, Saarela O, Tanguay S, Jewett M, Finelli A, Lacombe L, Kawakami J, Moore R, Morash C, Black P, Rendon RA.

Urol Oncol. 2017 Mar;35(3):124. doi: 10.1016/j.urolonc.2017.01.018. No abstract available.

PMID:
28215848
32.

Current guidelines do not sufficiently discriminate venous thromboembolism risk in urology.

McAlpine K, Breau RH, Mallick R, Cnossen S, Cagiannos I, Morash C, Carrier M, Lavallée LT.

Urol Oncol. 2017 Jul;35(7):457.e1-457.e8. doi: 10.1016/j.urolonc.2017.01.015. Epub 2017 Feb 15.

PMID:
28214280
33.

Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation.

Chung AD, Schieda N, Flood TA, Cagiannos I, Mai KT, Malone S, Morash C, Hakim SW, Breau RH.

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E50-E57. doi: 10.5489/cuaj.3789. Epub 2017 Jan 12.

34.

Quality indicators in the management of bladder cancer: A modified Delphi study.

Khare SR, Aprikian A, Black P, Blais N, Booth C, Brimo F, Chin J, Chung P, Drachenberg D, Eapen L, Fairey A, Fleshner N, Fradet Y, Gotto G, Izawa J, Jewett M, Kulkarni G, Lacombe L, Moore R, Morash C, North S, Rendon R, Saad F, Shayegan B, Siemens R, So A, Sridhar SS, Traboulsi SL, Kassouf W.

Urol Oncol. 2017 Jun;35(6):328-334. doi: 10.1016/j.urolonc.2016.12.003. Epub 2017 Jan 3.

PMID:
28065393
35.

Development and external validation of a biopsy-derived nomogram to predict risk of ipsilateral extraprostatic extension.

Sayyid R, Perlis N, Ahmad A, Evans A, Toi A, Horrigan M, Finelli A, Zlotta A, Kulkarni G, Hamilton R, Morash C, Fleshner N.

BJU Int. 2017 Jul;120(1):76-82. doi: 10.1111/bju.13733. Epub 2017 Jan 6.

36.

Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens.

Paterson NR, Lavallée LT, Nguyen LN, Witiuk K, Ross J, Mallick R, Shabana W, MacDonald B, Scheida N, Fergusson D, Momoli F, Cnossen S, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2016 Aug;10(7-8):264-268.

37.

Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy.

Lim CS, McInnes MDF, Lim RS, Breau RH, Flood TA, Krishna S, Morash C, Shabana WM, Schieda N.

J Magn Reson Imaging. 2017 Jul;46(1):257-266. doi: 10.1002/jmri.25539. Epub 2016 Nov 3.

PMID:
27807914
38.

Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline.

Salerno J, Finelli A, Morash C, Morgan SC, Power N, Schieda N, Haider MA.

Can Urol Assoc J. 2016 Sep-Oct;10(9-10):E332-E339. Epub 2016 Oct 13.

39.

Perineural invasion on biopsy is associated with upstaging at radical prostatectomy in Gleason score 3 + 4 = 7 prostate cancer.

Flood TA, Schieda N, Keefe DT, Morash C, Bateman J, Mai KT, Belanger EC, Robertson SJ, Breau RH.

Pathol Int. 2016 Nov;66(11):629-632. doi: 10.1111/pin.12467. Epub 2016 Oct 5.

PMID:
27709739
40.

MRI assessment of pathological stage and surgical margins in anterior prostate cancer (APC) using subjective and quantitative analysis.

Schieda N, Lim CS, Idris M, Lim RS, Morash C, Breau RH, Flood TA, McInnes MDF.

J Magn Reson Imaging. 2017 May;45(5):1296-1303. doi: 10.1002/jmri.25510. Epub 2016 Oct 11.

PMID:
27726247
41.

Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer.

Flood TA, Schieda N, Keefe DT, Breau RH, Morash C, Hogan K, Belanger EC, Mai KT, Robertson SJ.

Virchows Arch. 2016 Sep;469(3):313-9. doi: 10.1007/s00428-016-1981-2. Epub 2016 Jul 10.

PMID:
27394432
42.

The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.

Mason R, Kapoor A, Liu Z, Saarela O, Tanguay S, Jewett M, Finelli A, Lacombe L, Kawakami J, Moore R, Morash C, Black P, Rendon RA.

Urol Oncol. 2016 Nov;34(11):486.e1-486.e7. doi: 10.1016/j.urolonc.2016.05.025. Epub 2016 Jun 22. Erratum in: Urol Oncol. 2017 Mar;35(3):124.

PMID:
27344410
43.

Laparoscopic nephroureterectomy is associated with higher risk of adverse events compared to laparoscopic radical nephrectomy.

Bastiampillai R, Lavallée LT, Cnossen S, Witiuk K, Mallick R, Fergusson D, Schramm D, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2016 Mar-Apr;10(3-4):126-31. doi: 10.5489/cuaj.3362.

44.

Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Kassouf W, Aprikian A, Black P, Kulkarni G, Izawa J, Eapen L, Fairey A, So A, North S, Rendon R, Sridhar SS, Alam T, Brimo F, Blais N, Booth C, Chin J, Chung P, Drachenberg D, Fradet Y, Jewett M, Moore R, Morash C, Shayegan B, Gotto G, Fleshner N, Saad F, Siemens DR.

Can Urol Assoc J. 2016 Jan-Feb;10(1-2):E46-80. doi: 10.5489/cuaj.3583. Epub 2016 Feb 8. No abstract available.

45.

The effect of wide resection during radical prostatectomy on surgical margins.

Lavallée LT, Stokl A, Cnossen S, Mallick R, Morash C, Cagiannos I, Breau RH.

Can Urol Assoc J. 2016 Jan-Feb;10(1-2):14-7. doi: 10.5489/cuaj.3326.

46.

Active surveillance in Canadian men with low-grade prostate cancer.

Cristea O, Lavallée LT, Montroy J, Stokl A, Cnossen S, Mallick R, Fergusson D, Momoli F, Cagiannos I, Morash C, Breau RH.

CMAJ. 2016 May 17;188(8):E141-E147. doi: 10.1503/cmaj.150832. Epub 2016 Feb 29.

47.

Multiparametric MRI of the anterior prostate gland: clinical-radiological-histopathological correlation.

Moosavi B, Flood TA, Al-Dandan O, Breau RH, Cagiannos I, Morash C, Malone SC, Schieda N.

Clin Radiol. 2016 May;71(5):405-17. doi: 10.1016/j.crad.2016.01.002. Epub 2016 Feb 14. Review.

PMID:
26888762
48.

Reducing the Harm of Prostate Cancer Screening: Repeated Prostate-Specific Antigen Testing.

Lavallée LT, Binette A, Witiuk K, Cnossen S, Mallick R, Fergusson DA, Momoli F, Morash C, Cagiannos I, Breau RH.

Mayo Clin Proc. 2016 Jan;91(1):17-22. doi: 10.1016/j.mayocp.2015.07.030. Epub 2015 Dec 10.

PMID:
26688045
49.

Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy.

Gulavita P, Hakim SW, Schieda N, Breau RH, Morash C, Keefe DT, Robertson SJ, Mai KT, Belanger EC, Flood TA.

Can Urol Assoc J. 2015 Sep-Oct;9(9-10):302-6. doi: 10.5489/cuaj.2976.

50.

Pictorial review. Magnetic resonance for radiotherapy management and treatment planning in prostatic carcinoma.

Lim C, Malone SC, Avruch L, Breau RH, Flood TA, Lim M, Morash C, Quon JS, Walsh C, Schieda N.

Br J Radiol. 2015 Oct;88(1054):20150507. doi: 10.1259/bjr.20150507. Epub 2015 Aug 17. Review.

Supplemental Content

Loading ...
Support Center